Low Yield of Hepatitis B Virus DNA Testing in the Absence of Surface Antigen

Abstract

Get full access to this article

View all access options for this article.

References

Terrault

Lok

ASF

McMahon

, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67:1560-1599.

Mortensen

Kamali

Schirmer

, et al. Are current screening protocols for chronic hepatitis B virus infection adequate? Diagn Microbiol Infect Dis. 2016;85:159-167.

Brojer

Grabarczyk

Liszewski

Mikulska

Allain

Letowska

Characterization of HBV DNA/HBsAg− blood donors in Poland identified by triplex NAT. Hepatology. 2006;44:1666-1674.

Rodríguez-Torres

Gonzalez-Garcia

Bräu

, et al. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem? J Med Virol. 2007;79:694-700.

Hsu

Tsou

Lin

, et al. Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study. Hepatology. 2014;59:2092-2100.